Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients
- 1 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 13 (2) , 89-95
- https://doi.org/10.1097/00008571-200302000-00005
Abstract
Intestinal cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) both play a vital role in the metabolism of oral cyclosporine (CsA). We investigated the genetic polymorphisms in CYP3A4(promoter region and exons 5, 7 and 9) and MDR1 (exons 12, 21 and 26) genes and the impact of these polymorphisms on the pharmacokinetics of oral CsA in stable heart transplant patients (n = 14). CYP3A4 polymorphisms were rare in the Asian population and transplant patients. Haplotype analysis revealed 12 haplotypes in the Chinese, eight in the Malays and 10 in the Indians. T-T-T was the most common haplotype in all ethnic groups. The frequency of the homozygous mutant genotype at all three loci (TT-TT-TT) was highest in the Indians (31%) compared to 19% and 15% in the Chinese and Malays, respectively. In heart transplant patients, CsA exposure (AUC(0-4 h), AUC(0-12 h) and C(max)) was high in patients with the T-T-T haplotypes compared to those with C-G-C haplotypes. These findings suggest that haplotypes rather than genotypes influence CsA disposition in transplant patients.Keywords
This publication has 16 references indexed in Scilit:
- Identification of functionally variant MDR1 alleles among European Americans and African AmericansClinical Pharmacology & Therapeutics, 2001
- Frequency of C3435T polymorphism of MDR1 gene in African peopleThe Lancet, 2001
- MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicityPharmacogenetics, 2001
- Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjectsClinical Pharmacology & Therapeutics, 2001
- MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.Pharmaceutical Research, 2001
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4Clinical Pharmacology & Therapeutics, 1999
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4JNCI Journal of the National Cancer Institute, 1998
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986